About Alderley Analytical
Alderley Analytical is a company based in Stockport (United Kingdom) founded in 2013 by Elizabeth Thomas, Claire Wildgoose, Paul Holme, and Sally Hannam was acquired by Synexa Life Sciences in October 2024. Alderley Analytical has raised $869.35 thousand across 2 funding rounds from investors including Synexa Life Sciences, BioCity and Northern Powerhouse Investment Fund. The company has 41 employees as of January 31, 2021. Alderley Analytical offers products and services including Preclinical Bioanalysis, Clinical Bioanalysis, GLP Regulatory Bioanalysis, Toxicokinetics, and Biomarker Analysis. Alderley Analytical operates in a competitive market with competitors including BioAgilytix, Advion, Tentamus, Nordic Bioscience and Evans Analytical Group, among others.
- Headquarter Stockport, United Kingdom
- Employees 41 as on 31 Jan, 2021
- Founders Elizabeth Thomas, Claire Wildgoose, Paul Holme, Sally Hannam
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Alderley Analytical Ltd
- Date of Incorporation 27 Aug, 2013
- Jurisdiction MACCLESFIELD, CHESHIRE, ENGLAND
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$869.35 K (USD)
in 2 rounds
-
Latest Funding Round
$400.49 K (USD), Seed
Jun 05, 2018
-
Investors
Synexa Life Sciences
& 3 more
-
Employee Count
41
as on Jan 31, 2021
-
Acquired by
Synexa Life Sciences
(Oct 07, 2024)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Alderley Analytical
Alderley Analytical offers a comprehensive portfolio of products and services, including Preclinical Bioanalysis, Clinical Bioanalysis, GLP Regulatory Bioanalysis, Toxicokinetics, and Biomarker Analysis.
Supports drug discovery and safety testing for preclinical phases.
Handles immunogenicity and biomarker analysis in clinical development.
Ensures compliance with guidelines for regulatory bioanalysis.
Evaluates drug kinetics and safety in development programs.
Provides analysis for biomarkers in drug research and testing.
Funding Insights of Alderley Analytical
Alderley Analytical has successfully raised a total of $869.35K across 2 strategic funding rounds. The most recent funding activity was a Seed round of $400.49 thousand completed in June 2018. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Alderley Analytical
Alderley Analytical has secured backing from 4 investors, including venture fund investors. Prominent investors backing the company include Synexa Life Sciences, BioCity and Northern Powerhouse Investment Fund.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Private debt is extended to early-stage companies and SMEs.
|
Locked | Locked | Locked | |
|
Venture debt firm
|
Locked | Locked | Locked | |
|
Life Science focused startup accelerator and incubator
|
Locked | Locked | Locked |
Investor details for Alderley Analytical
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Alderley Analytical
Investment portfolio details for Alderley Analytical
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Alderley Analytical
Detailed financials for Alderley Analytical
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Alderley Analytical Comparisons
Peer comparison for Alderley Analytical
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Alderley Analytical
Alderley Analytical operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as BioAgilytix, Advion, Tentamus, Nordic Bioscience and Evans Analytical Group, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Large-molecule bioanalysis is provided for biologics and biosimilars development.
|
|
| Locked | Locked | Locked |
Microfluidics and mass spectrometry products are provided for clinical research.
|
|
| Locked | Locked | Locked |
Analytical and quality assurance services are provided for diverse industries.
|
|
| Locked | Locked | Locked |
Preclinical and clinical drug development CRO with proprietary in-house Biomarker platform
|
|
| Locked | Locked | Locked |
Company offering a suite of scientific services for materials, engineering, agri, and life science industries
|
Detailed competitors of Alderley Analytical
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Alderley Analytical
Complete news archive for Alderley Analytical
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Alderley Analytical
Alderley Analytical was founded in 2013 and raised its 1st funding round 3 years after it was founded.
Alderley Analytical is headquartered in Stockport, United Kingdom. It is registered at Stockport, Greater Manchester, United Kingdom.
Elizabeth Thomas is the current CEO of Alderley Analytical. They have also founded this company.
Alderley Analytical is a funded company, having raised a total of $869.35K across 2 funding rounds to date.
As of Jan 31, 2021, the latest employee count at Alderley Analytical is 41.
Alderley Analytical was established in 2013 as a Contract Research Organisation based in Stockport, United Kingdom. Bioanalytical services are provided for pre-clinical and clinical phases of drug development. Assays are developed and validated for small molecules, peptides, large molecules, and biomarkers. Analysis support is extended across all stages of the drug development process within the pharmaceutical sector.
Alderley Analytical's top competitors include BioAgilytix, Lightcast Discovery and Solvias.
Alderley Analytical offers Preclinical Bioanalysis, Clinical Bioanalysis, GLP Regulatory Bioanalysis, Toxicokinetics, and Biomarker Analysis.
Alderley Analytical has 4 investors. Key investors include Synexa Life Sciences, BioCity, Northern Powerhouse Investment Fund, and The North West Fund.